Effect of ascorbic and chondrogenic derived decellularized extracellular matrix from mesenchymal stem cells on their proliferation, viability and differentiation

The development and application of biomaterials to promote stem cell proliferation and differentiation has undergone major expansion over the last few years. Decellularized stem cell matrix (DSCMs) represent bioactive and biocompatible materials which achieve similar characteristics of native extrac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of anatomy 2018-11, Vol.220, p.60-69
Hauptverfasser: Pérez-Castrillo, S., González-Fernández, M.L., López-González, M.E., Villar-Suárez, V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 69
container_issue
container_start_page 60
container_title Annals of anatomy
container_volume 220
creator Pérez-Castrillo, S.
González-Fernández, M.L.
López-González, M.E.
Villar-Suárez, V.
description The development and application of biomaterials to promote stem cell proliferation and differentiation has undergone major expansion over the last few years. Decellularized stem cell matrix (DSCMs) represent bioactive and biocompatible materials which achieve similar characteristics of native extracellular matrix. DSCMs have given promising outcomes in generating novel cell culture substrates mimicking specific niche microenvironments in tissue engineering. This research aims at producing two different DSCMs obtained from adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, characterize them and evaluate the DSCMs bioactivity on mesenchymal stem cells. DSCMs were produced using ascorbic or chondrogenic medium, which were then used as a scaffold for adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, respectively. The biological characteristics of both types of DSCMs, including cell attachment, morphology, proliferation, viability, and chondrogenic and osteogenic differentiation were evaluated and compared. Differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs were found. Chondrogenic derived-DSCMs remained compact and stronger during extraction and this made their handling easier. Ascorbic derived-DSCMs showed a different protein composition to chondrogenic-DSCMs. Bioactive characteristics analyzed were different depending on the cellular origin of DSCM and the method used to produce them. The DSCMs obtained in this work constitutes favorable structure- and growth factors providing a microenvironment which is very similar to that of native ECM, which results in enhanced biological potential of the MSCs and responsiveness to the induction of differentiation. We found differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs. Our results suggest that the cell source used to produce DSCMs is highly related to the bioactive characteristics of DSCMs.
doi_str_mv 10.1016/j.aanat.2018.07.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2089857156</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0940960218301055</els_id><sourcerecordid>2089857156</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-89ab95238ad488345015e7018b72a07118f6d00adbc937d79c1bad29b1329c0c3</originalsourceid><addsrcrecordid>eNp9kc9uEzEQxi1ERdPCEyAhHzmw2_H-tQ8cUFUoUqVe4GzN2rPE0e662E7U8Da8aZ2k5chp5PE3_j7Pj7H3AkoBorvalIgLprICIUvoS4DuFVuJTsgCGqhesxWoBgrVQXXOLmLcANRd2zVv2HkNQjRNo1bs7804kkncjxyj8WFwhuNiuVn7xQb_i5bcsBTcjmyuhqZpO2Fwf_KRHlPAlw6fMQX3yMfgZz5TpMWs9zNOPCaa-UEVuV94WpML_CH4yY0UMDm_fOI7h4ObXNofra3LkQItyR2v37KzEadI757rJfv59ebH9W1xd__t-_WXu8LUrUqFVDiotqol2kbKumlBtNTn1Qx9hdALIcfOAqAdjKp72ysjBrSVGkRdKQOmvmQfT-_mcL-3FJOeXTzkxoX8NuoKpJJtL9ouS-uT1AQfY6BRPwQ3Y9hrAfrARm_0kY0-sNHQ68wmT314NtgOM9l_My8wsuDzSUD5mztHQUfj8h7JupAZaevdfw2eAC0_pP4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2089857156</pqid></control><display><type>article</type><title>Effect of ascorbic and chondrogenic derived decellularized extracellular matrix from mesenchymal stem cells on their proliferation, viability and differentiation</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Pérez-Castrillo, S. ; González-Fernández, M.L. ; López-González, M.E. ; Villar-Suárez, V.</creator><creatorcontrib>Pérez-Castrillo, S. ; González-Fernández, M.L. ; López-González, M.E. ; Villar-Suárez, V.</creatorcontrib><description>The development and application of biomaterials to promote stem cell proliferation and differentiation has undergone major expansion over the last few years. Decellularized stem cell matrix (DSCMs) represent bioactive and biocompatible materials which achieve similar characteristics of native extracellular matrix. DSCMs have given promising outcomes in generating novel cell culture substrates mimicking specific niche microenvironments in tissue engineering. This research aims at producing two different DSCMs obtained from adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, characterize them and evaluate the DSCMs bioactivity on mesenchymal stem cells. DSCMs were produced using ascorbic or chondrogenic medium, which were then used as a scaffold for adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, respectively. The biological characteristics of both types of DSCMs, including cell attachment, morphology, proliferation, viability, and chondrogenic and osteogenic differentiation were evaluated and compared. Differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs were found. Chondrogenic derived-DSCMs remained compact and stronger during extraction and this made their handling easier. Ascorbic derived-DSCMs showed a different protein composition to chondrogenic-DSCMs. Bioactive characteristics analyzed were different depending on the cellular origin of DSCM and the method used to produce them. The DSCMs obtained in this work constitutes favorable structure- and growth factors providing a microenvironment which is very similar to that of native ECM, which results in enhanced biological potential of the MSCs and responsiveness to the induction of differentiation. We found differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs. Our results suggest that the cell source used to produce DSCMs is highly related to the bioactive characteristics of DSCMs.</description><identifier>ISSN: 0940-9602</identifier><identifier>EISSN: 1618-0402</identifier><identifier>DOI: 10.1016/j.aanat.2018.07.006</identifier><identifier>PMID: 30114449</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Adipocytes - drug effects ; Adipose derived mesenchymal stem cells ; Animals ; Ascorbic Acid - pharmacology ; Biocompatible Materials ; Bone and Bones - cytology ; Bone Marrow Cells ; Bone marrow mesenchymal stem cells ; Cell Adhesion - drug effects ; Cell Differentiation - drug effects ; Cell Proliferation - drug effects ; Cell proliferation and differentiation ; Cell Survival - drug effects ; Chondrogenesis ; Decellularized matrix ; Extracellular Matrix - drug effects ; Horses ; Mesenchymal Stem Cells - drug effects ; Osteogenesis - drug effects ; Tissue Scaffolds</subject><ispartof>Annals of anatomy, 2018-11, Vol.220, p.60-69</ispartof><rights>2018 Elsevier GmbH</rights><rights>Copyright © 2018 Elsevier GmbH. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-89ab95238ad488345015e7018b72a07118f6d00adbc937d79c1bad29b1329c0c3</citedby><cites>FETCH-LOGICAL-c359t-89ab95238ad488345015e7018b72a07118f6d00adbc937d79c1bad29b1329c0c3</cites><orcidid>0000-0002-4374-7492</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.aanat.2018.07.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30114449$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pérez-Castrillo, S.</creatorcontrib><creatorcontrib>González-Fernández, M.L.</creatorcontrib><creatorcontrib>López-González, M.E.</creatorcontrib><creatorcontrib>Villar-Suárez, V.</creatorcontrib><title>Effect of ascorbic and chondrogenic derived decellularized extracellular matrix from mesenchymal stem cells on their proliferation, viability and differentiation</title><title>Annals of anatomy</title><addtitle>Ann Anat</addtitle><description>The development and application of biomaterials to promote stem cell proliferation and differentiation has undergone major expansion over the last few years. Decellularized stem cell matrix (DSCMs) represent bioactive and biocompatible materials which achieve similar characteristics of native extracellular matrix. DSCMs have given promising outcomes in generating novel cell culture substrates mimicking specific niche microenvironments in tissue engineering. This research aims at producing two different DSCMs obtained from adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, characterize them and evaluate the DSCMs bioactivity on mesenchymal stem cells. DSCMs were produced using ascorbic or chondrogenic medium, which were then used as a scaffold for adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, respectively. The biological characteristics of both types of DSCMs, including cell attachment, morphology, proliferation, viability, and chondrogenic and osteogenic differentiation were evaluated and compared. Differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs were found. Chondrogenic derived-DSCMs remained compact and stronger during extraction and this made their handling easier. Ascorbic derived-DSCMs showed a different protein composition to chondrogenic-DSCMs. Bioactive characteristics analyzed were different depending on the cellular origin of DSCM and the method used to produce them. The DSCMs obtained in this work constitutes favorable structure- and growth factors providing a microenvironment which is very similar to that of native ECM, which results in enhanced biological potential of the MSCs and responsiveness to the induction of differentiation. We found differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs. Our results suggest that the cell source used to produce DSCMs is highly related to the bioactive characteristics of DSCMs.</description><subject>Adipocytes - drug effects</subject><subject>Adipose derived mesenchymal stem cells</subject><subject>Animals</subject><subject>Ascorbic Acid - pharmacology</subject><subject>Biocompatible Materials</subject><subject>Bone and Bones - cytology</subject><subject>Bone Marrow Cells</subject><subject>Bone marrow mesenchymal stem cells</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell proliferation and differentiation</subject><subject>Cell Survival - drug effects</subject><subject>Chondrogenesis</subject><subject>Decellularized matrix</subject><subject>Extracellular Matrix - drug effects</subject><subject>Horses</subject><subject>Mesenchymal Stem Cells - drug effects</subject><subject>Osteogenesis - drug effects</subject><subject>Tissue Scaffolds</subject><issn>0940-9602</issn><issn>1618-0402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9uEzEQxi1ERdPCEyAhHzmw2_H-tQ8cUFUoUqVe4GzN2rPE0e662E7U8Da8aZ2k5chp5PE3_j7Pj7H3AkoBorvalIgLprICIUvoS4DuFVuJTsgCGqhesxWoBgrVQXXOLmLcANRd2zVv2HkNQjRNo1bs7804kkncjxyj8WFwhuNiuVn7xQb_i5bcsBTcjmyuhqZpO2Fwf_KRHlPAlw6fMQX3yMfgZz5TpMWs9zNOPCaa-UEVuV94WpML_CH4yY0UMDm_fOI7h4ObXNofra3LkQItyR2v37KzEadI757rJfv59ebH9W1xd__t-_WXu8LUrUqFVDiotqol2kbKumlBtNTn1Qx9hdALIcfOAqAdjKp72ysjBrSVGkRdKQOmvmQfT-_mcL-3FJOeXTzkxoX8NuoKpJJtL9ouS-uT1AQfY6BRPwQ3Y9hrAfrARm_0kY0-sNHQ68wmT314NtgOM9l_My8wsuDzSUD5mztHQUfj8h7JupAZaevdfw2eAC0_pP4</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Pérez-Castrillo, S.</creator><creator>González-Fernández, M.L.</creator><creator>López-González, M.E.</creator><creator>Villar-Suárez, V.</creator><general>Elsevier GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4374-7492</orcidid></search><sort><creationdate>20181101</creationdate><title>Effect of ascorbic and chondrogenic derived decellularized extracellular matrix from mesenchymal stem cells on their proliferation, viability and differentiation</title><author>Pérez-Castrillo, S. ; González-Fernández, M.L. ; López-González, M.E. ; Villar-Suárez, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-89ab95238ad488345015e7018b72a07118f6d00adbc937d79c1bad29b1329c0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adipocytes - drug effects</topic><topic>Adipose derived mesenchymal stem cells</topic><topic>Animals</topic><topic>Ascorbic Acid - pharmacology</topic><topic>Biocompatible Materials</topic><topic>Bone and Bones - cytology</topic><topic>Bone Marrow Cells</topic><topic>Bone marrow mesenchymal stem cells</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell proliferation and differentiation</topic><topic>Cell Survival - drug effects</topic><topic>Chondrogenesis</topic><topic>Decellularized matrix</topic><topic>Extracellular Matrix - drug effects</topic><topic>Horses</topic><topic>Mesenchymal Stem Cells - drug effects</topic><topic>Osteogenesis - drug effects</topic><topic>Tissue Scaffolds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pérez-Castrillo, S.</creatorcontrib><creatorcontrib>González-Fernández, M.L.</creatorcontrib><creatorcontrib>López-González, M.E.</creatorcontrib><creatorcontrib>Villar-Suárez, V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of anatomy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pérez-Castrillo, S.</au><au>González-Fernández, M.L.</au><au>López-González, M.E.</au><au>Villar-Suárez, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of ascorbic and chondrogenic derived decellularized extracellular matrix from mesenchymal stem cells on their proliferation, viability and differentiation</atitle><jtitle>Annals of anatomy</jtitle><addtitle>Ann Anat</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>220</volume><spage>60</spage><epage>69</epage><pages>60-69</pages><issn>0940-9602</issn><eissn>1618-0402</eissn><abstract>The development and application of biomaterials to promote stem cell proliferation and differentiation has undergone major expansion over the last few years. Decellularized stem cell matrix (DSCMs) represent bioactive and biocompatible materials which achieve similar characteristics of native extracellular matrix. DSCMs have given promising outcomes in generating novel cell culture substrates mimicking specific niche microenvironments in tissue engineering. This research aims at producing two different DSCMs obtained from adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, characterize them and evaluate the DSCMs bioactivity on mesenchymal stem cells. DSCMs were produced using ascorbic or chondrogenic medium, which were then used as a scaffold for adipose derived mesenchymal stem cells and bone marrow mesenchymal stem cells, respectively. The biological characteristics of both types of DSCMs, including cell attachment, morphology, proliferation, viability, and chondrogenic and osteogenic differentiation were evaluated and compared. Differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs were found. Chondrogenic derived-DSCMs remained compact and stronger during extraction and this made their handling easier. Ascorbic derived-DSCMs showed a different protein composition to chondrogenic-DSCMs. Bioactive characteristics analyzed were different depending on the cellular origin of DSCM and the method used to produce them. The DSCMs obtained in this work constitutes favorable structure- and growth factors providing a microenvironment which is very similar to that of native ECM, which results in enhanced biological potential of the MSCs and responsiveness to the induction of differentiation. We found differences between ascorbic derived-DSCMs and chondrogenic derived DSCMs. Our results suggest that the cell source used to produce DSCMs is highly related to the bioactive characteristics of DSCMs.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>30114449</pmid><doi>10.1016/j.aanat.2018.07.006</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4374-7492</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0940-9602
ispartof Annals of anatomy, 2018-11, Vol.220, p.60-69
issn 0940-9602
1618-0402
language eng
recordid cdi_proquest_miscellaneous_2089857156
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adipocytes - drug effects
Adipose derived mesenchymal stem cells
Animals
Ascorbic Acid - pharmacology
Biocompatible Materials
Bone and Bones - cytology
Bone Marrow Cells
Bone marrow mesenchymal stem cells
Cell Adhesion - drug effects
Cell Differentiation - drug effects
Cell Proliferation - drug effects
Cell proliferation and differentiation
Cell Survival - drug effects
Chondrogenesis
Decellularized matrix
Extracellular Matrix - drug effects
Horses
Mesenchymal Stem Cells - drug effects
Osteogenesis - drug effects
Tissue Scaffolds
title Effect of ascorbic and chondrogenic derived decellularized extracellular matrix from mesenchymal stem cells on their proliferation, viability and differentiation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A21%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20ascorbic%20and%20chondrogenic%20derived%20decellularized%20extracellular%20matrix%20from%20mesenchymal%20stem%20cells%20on%20their%20proliferation,%20viability%20and%20differentiation&rft.jtitle=Annals%20of%20anatomy&rft.au=P%C3%A9rez-Castrillo,%20S.&rft.date=2018-11-01&rft.volume=220&rft.spage=60&rft.epage=69&rft.pages=60-69&rft.issn=0940-9602&rft.eissn=1618-0402&rft_id=info:doi/10.1016/j.aanat.2018.07.006&rft_dat=%3Cproquest_cross%3E2089857156%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2089857156&rft_id=info:pmid/30114449&rft_els_id=S0940960218301055&rfr_iscdi=true